These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35081408)

  • 1. Atomic-Layer Deposition Processes Applied to Phage λ and a Phage-like Particle Platform Yield Thermostable, Single-Shot Vaccines.
    Witeof AE; McClary WD; Rea LT; Yang Q; Davis MM; Funke HH; Catalano CE; Randolph TW
    J Pharm Sci; 2022 May; 111(5):1354-1362. PubMed ID: 35081408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-administration, thermostable human papillomavirus vaccines prepared with atomic layer deposition technology.
    Garcea RL; Meinerz NM; Dong M; Funke H; Ghazvini S; Randolph TW
    NPJ Vaccines; 2020; 5(1):45. PubMed ID: 32528733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single Dose, Thermostable, Trivalent Human Papillomavirus Vaccine Formulated Using Atomic Layer Deposition.
    Witeof AE; Meinerz NM; Walker KD; Funke HH; Garcea RL; Randolph TW
    J Pharm Sci; 2023 Aug; 112(8):2223-2229. PubMed ID: 36780987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstituted dry powder formulations of ZnO-adjuvanted ovalbumin induce equivalent antigen specific antibodies but lower T cell responses than ovalbumin adjuvanted with Alhydrogel® or cationic adjuvant formulation 01 (CAF®01).
    Hellfritzsch M; Christensen D; Foged C; Scherließ R; Thakur A
    Int J Pharm; 2023 Dec; 648():123581. PubMed ID: 37931728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.
    Davenport BJ; Catala A; Weston SM; Johnson RM; Ardanuy J; Hammond HL; Dillen C; Frieman MB; Catalano CE; Morrison TE
    NPJ Vaccines; 2022 May; 7(1):57. PubMed ID: 35618725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
    Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
    J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Gomez M; McCollum J; Wang H; Bachchhav S; Tetreau I; Gerhardt A; Press C; Kramer RM; Fox CB; Vehring R
    Vaccine; 2021 Aug; 39(35):5025-5036. PubMed ID: 34256969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy.
    Malik DJ
    Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle.
    Jepson CD; March JB
    Vaccine; 2004 Jun; 22(19):2413-9. PubMed ID: 15193403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus.
    Saboo S; Tumban E; Peabody J; Wafula D; Peabody DS; Chackerian B; Muttil P
    Mol Pharm; 2016 May; 13(5):1646-55. PubMed ID: 27019231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.
    Maa YF; Ameri M; Rigney R; Payne LG; Chen D
    Pharm Res; 2004 Mar; 21(3):515-23. PubMed ID: 15070104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines.
    Gomez M; Vehring R
    J Aerosol Med Pulm Drug Deliv; 2022 Jun; 35(3):121-138. PubMed ID: 35172104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray-Dried Influenza Antigen with Trehalose and Leucine Produces an Aerosolizable Powder Vaccine Formulation that Induces Strong Systemic and Mucosal Immunity after Pulmonary Administration.
    Sou T; Morton DA; Williamson M; Meeusen EN; Kaminskas LM; McIntosh MP
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):361-71. PubMed ID: 25714115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing CAF-adjuvanted dry powder vaccines: spray drying preserves the adjuvant activity of CAF01.
    Ingvarsson PT; Schmidt ST; Christensen D; Larsen NB; Hinrichs WL; Andersen P; Rantanen J; Nielsen HM; Yang M; Foged C
    J Control Release; 2013 May; 167(3):256-64. PubMed ID: 23415813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developments in the formulation and delivery of spray dried vaccines.
    Kanojia G; Have RT; Soema PC; Frijlink H; Amorij JP; Kersten G
    Hum Vaccin Immunother; 2017 Oct; 13(10):2364-2378. PubMed ID: 28925794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates.
    Scherließ R; Ajmera A; Dennis M; Carroll MW; Altrichter J; Silman NJ; Scholz M; Kemter K; Marriott AC
    Vaccine; 2014 Apr; 32(19):2231-40. PubMed ID: 24631078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V; Amorij JP; Kapteyn JC; de Boer AH; Frijlink HW; Hinrichs WL
    J Control Release; 2010 Jun; 144(2):127-33. PubMed ID: 20219608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
    Tumban E; Muttil P; Escobar CA; Peabody J; Wafula D; Peabody DS; Chackerian B
    Vaccine; 2015 Jun; 33(29):3346-53. PubMed ID: 26003490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stable live bacterial vaccine.
    Kunda NK; Wafula D; Tram M; Wu TH; Muttil P
    Eur J Pharm Biopharm; 2016 Jun; 103():109-117. PubMed ID: 27020530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.